Article
Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study.
Malaria journal - 29 Oct 2015
Ndounga Mathieu, Pembe Issamou Mayengue, Casimiro Prisca Nadine, Koukouikila-Koussounda Félix, Bitemo Michel, Diassivy Matondo Brunelle, Ndounga Diakou Lee Aymar, Basco Leonardo K, Ntoumi Francine
Abstract excerpt
BACKGROUND: The Republic of Congo adopted a new anti-malarial treatment policy in 2006, with artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) as the first- and second-line anti-malarial drugs, respectively. Only three clinical studies had been conducted before the policy change. A randomized study on these two artemisinin-based combinations was conducted, and the effect that sickle cell trait may...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.